RecruitingNot ApplicableNCT06431269
Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
Sponsor
University Hospital, Montpellier
Enrollment
270 participants
Start Date
May 31, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease
Eligibility
Min Age: 1 YearMax Age: 5 Years
Inclusion Criteria6
- Congenital heart disease with stable status defined by last operation >3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
- Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
- Patient aged 1 to 5 years.
- No previous medical diagnosis of NDD
- Parental or legal guardian's consent.
- Social security affiliation (for France only)
Exclusion Criteria3
- Patients with a genetic or poly-malformative syndrome with known neurological impairment.
- Neurodevelopmental disorder already known/treated
- Neurodevelopmental status evaluation within the last 6 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERScreening for neurodevelopmental disorders by an advanced practice nurse
Screening for neurodevelopmental disorders by an advanced practice nurse with Ages \& Stages Questionnaires (ASQ-3) and Haute Autorité de Santé (HAS) identification scale
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06431269
Related Trials
Homelessness and Prevalence of Neurodevelopmental Disorders
NCT068699151 location
Neuraxial Labor Analgesia and Offspring Neurodevelopment
NCT049642062 locations
Perinatal Covid-19 Infection, NO Pathway, and Minipuberty
NCT049528702 locations
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
NCT060151911 location
Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders
NCT073876271 location